Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Current Assets: 2020-2024

Historic Current Assets for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Dec 2024 value amounting to $429.1 million.

  • Maravai Lifesciences Holdings' Current Assets fell 52.02% to $325.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $325.9 million, marking a year-over-year decrease of 52.02%. This contributed to the annual value of $429.1 million for FY2024, which is 38.69% down from last year.
  • Maravai Lifesciences Holdings' Current Assets amounted to $429.1 million in FY2024, which was down 38.69% from $699.9 million recorded in FY2023.
  • Maravai Lifesciences Holdings' 5-year Current Assets high stood at $847.9 million for FY2022, and its period low was $331.6 million during FY2020.
  • Over the past 3 years, Maravai Lifesciences Holdings' median Current Assets value was $699.9 million (recorded in 2023), while the average stood at $659.0 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Current Assets skyrocketed by 123.17% in 2021, and later plummeted by 38.69% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' Current Assets (Yearly) stood at $331.6 million in 2020, then skyrocketed by 123.17% to $740.0 million in 2021, then grew by 14.58% to $847.9 million in 2022, then decreased by 17.45% to $699.9 million in 2023, then plummeted by 38.69% to $429.1 million in 2024.